It is only in those dogs that have no viral antibody that the vaccine will booster the immune system, both the cellular and
humoral response to the virus.
It is only in those dogs that have no viral antibody that the vaccine will boost the immune system, both the cellular and
humoral response to the virus.
Not exact matches
(**) C. Hammer et al.: Amino Acid Variation in HLA Class II Proteins Is a Major Determinant of
Humoral Response to Common
Viruses.
Evaluation of the ability of canarypox - vectored equine influenza
virus vaccines
to induce
humoral immune
responses against canine influenza
viruses in dogs.
The development of CMI is the most crucial factor in determining the ultimate outcome of FIPV infection.4, 5,12 Cats that produce
humoral antibodies but fail
to generate an effective CMI
response develop effusive FIP.4, 5 Experimental evidence demonstrates that cats with non-effusive FIP often have preceding, transient effusive disease.4 Thus, noneffusive FIP is believed
to result from a partially protective CMI
response that is unable
to wall off and contain the
virus.4
The rationale for selecting CPV and CDV for serum antibody testing is based on the clinically important diseases they cause, combined with the usefulness of the host's
humoral immune
response to these
viruses for determining the need for revaccination.